Little is known about the relationship between mTOR and ROS in cervical cancer, but recent studies suggest that HPV oncoproteins may be involved in the activation of the PI3K/Akt/mTOR pathway, potentially promoting tumorigenesis (Cruz-Gregorio and Aranda-Rivera, 2021). This evidence concerns the gene MTOR and cervical carcinoma.